Can I read DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2 on EtoBox?

DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2 by Yadav, Pooja (author);Rana, Meenakshi (author);Chowdhury, Papia (author) is a Chemistry article available to read on EtoBox.

What is DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2 about?

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Who reads DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2?

Author

Yadav, Pooja (author);Rana, Meenakshi (author);Chowdhury, Papia (author)

Publisher

Elsevier BV

Published

2021

Language

EN

Field

Chemistry (Physical Sciences)